SCHEMBL8553634

SCHEMBL8553634

CCCCOC(=O)N1CCCC(CC(=O)OCC)C1

nearest known ligand 0.45

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
POLB P06746 3/20 0.45
LMNA P02545 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
ALDH1A1 P00352 2/20 0.39
MEN1 O00255 1/20 0.38
MAPT P10636 1/20 0.38
KMT2A Q03164 1/20 0.38
THRB P10828 1/20 0.38
ATM Q13315 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
CYP1A2 P05177 1/20 0.38
GAA P10253 2/20 0.38
CHRM1 P11229 1/20 0.36
GLS O94925 1/20 0.36
KDM4E B2RXH2 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11088727 0.91 ALDH1A1 (0.45) POLBSMN1; SMN2ALDH1A1THRBATM
SCHEMBL13174685 0.90 POLB (0.48) POLBLMNASMN1; SMN2ALDH1A1THRB
SCHEMBL8554245 0.88 POLB (0.43) POLBLMNASMN1; SMN2ALDH1A1MEN1
SCHEMBL4200215 0.86 POLB (0.46) POLBLMNASMN1; SMN2ALDH1A1MEN1
SCHEMBL8324568 0.85 POLB (0.50) POLBLMNASMN1; SMN2ALDH1A1MEN1
SCHEMBL29812927 0.84 SMN1; SMN2 (0.49) POLBLMNASMN1; SMN2ALDH1A1MEN1
SCHEMBL13174683 0.84 POLB (0.52) POLBLMNASMN1; SMN2ALDH1A1MAPT
SCHEMBL4599962 0.84 SMN1; SMN2 (0.49) POLBLMNASMN1; SMN2ALDH1A1MEN1
SCHEMBL30089091 0.83 POLB (0.48) POLBLMNASMN1; SMN2ALDH1A1MEN1
SCHEMBL2125428 0.83 POLB (0.48) POLBLMNASMN1; SMN2ALDH1A1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0871442-A1 BENZIMIDZOLYL NEUROPEPTIDE Y RECEPTOR ANTAGONISTS ELI LILLY AND COMPANY (US) 1998-10-21 EP disclosed
WO-1997025041-A1 BENZIMIDZOLYL NEUROPEPTIDE Y RECEPTOR ANTAGONISTS ELI LILLY AND COMPANY (US) 1997-07-17 WO disclosed